New Tech on the Rise: The Future of Cell and Gene Therapies is Here

The advanced therapy industry has shown great promise in treating rare and genetic diseases, but have encountered roadblocks in safety, affordability, and accessibility. The patient populations of these diseases have long been without options, these advancements have inspired hope and the possibility of receiving an effective treatment. However, these immense efforts are in vain if they come with detrimental or life-threatening side effects or are simply unaffordable for the patients they intend to treat.

Anshul Mangal, President of Project Farma and Precision ADVANCE, addresses increasing accessibility in advanced therapies and the rise of new gene editing technologies in “New Tech on the Rise: The Future of Cell and Gene Therapies is Here.”

To read the article in full, click here!